Jun Cai Bai

AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.

Ambio, Inc. is an American company that provides a platform for searching, comparing, requesting, and purchasing sustainable plastics from top material distributors and manufacturers. The private company is based in SC. The company's platform allows customers to quickly and easily find recycled and bio-based plastic materials at competitive prices, while also saving time by handling the search and logistics from start to finish.

Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC.

Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC.

Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC.

Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC.

AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.

Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC.

Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC.

Ambio Holdings, Inc. operates as a pharmaceutical company which focuses on complex peptides. It develops processes for manufacturing peptides at small to large scale as active pharmaceutical ingredients used in New Chemical Entities and generic peptides by clients worldwide. The company was founded by Chris J. Bai in 2014 and is headquartered in North Augusta, SC.

Ambio, Inc. is an American company that provides a platform for searching, comparing, requesting, and purchasing sustainable plastics from top material distributors and manufacturers. The private company is based in SC. The company's platform allows customers to quickly and easily find recycled and bio-based plastic materials at competitive prices, while also saving time by handling the search and logistics from start to finish.

AmbioPharm, Inc. is a pharmaceutical manufacturing company based in South Carolina. The American company specializes in the production of pharmaceuticals. Brian Gregg has been the CEO of the private company since 2023.

Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC.